<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00965302</url>
  </required_header>
  <id_info>
    <org_study_id>FWH20090068H</org_study_id>
    <nct_id>NCT00965302</nct_id>
  </id_info>
  <brief_title>Sleeve Gastrectomy Versus Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients</brief_title>
  <official_title>Sleeve Gastrectomy vs Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wilford Hall Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wilford Hall Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to randomize mild to moderately obese (BMI 30-34.9) subjects to
      medical management (diet, exercise, and best medical therapy) versus sleeve gastrectomy with
      medical management, with a primary endpoint of diabetes remission (normal fasting glucose,
      off medications and insulin) at one year. Sleeve gastrectomy (also called greater curvature
      gastrectomy, vertical sleeve gastrectomy, and sleeve gastroplasty) involves stapled resection
      of the gastric fundus. Secondary endpoints include weight loss, improvement in hypertension,
      sleep apnea, c-reactive protein, and fasting lipid profile.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diabetes remission</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight loss</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obstructive sleep apnea remission</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting lipid profile</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>c-reactive protein</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Intensive medical management of Type 2 DM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intensive medical management of Type II diabetes will include visits every three months for a year with an endocrinologist, with lifestyle counseling, weight management, regular exercise, and glucose control forming the core of the medical therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic sleeve gastrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic sleeve gastrectomy is performed as part of a bariatric surgical program emphasizing healthy dietary choices, regular exercise, and glucose control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic sleeve gastrectomy</intervention_name>
    <description>Laparoscopic sleeve gastrectomy, also known as vertical sleeve gastrectomy, sleeve gastroplasty, or sleeve gastrectomy, will be performed over a 32 to 40 French sizing bougie.</description>
    <arm_group_label>Laparoscopic sleeve gastrectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intensive medical management</intervention_name>
    <description>Intensive medical therapy for Diabetes mellitus, Type 2, will include weight management counseling, exercise, glucose control, and healthy dietary choices.</description>
    <arm_group_label>Intensive medical management of Type 2 DM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetes mellitus, Type 2

          -  Body Mass Index (BMI) 30-34.9

          -  Able to understand and comply with study process

        Exclusion Criteria:

          -  Pregnancy

          -  Prior bariatric surgery

          -  Diabetes mellitus, Type 1

          -  Renal impairment

          -  Cirrhosis or portal hypertension

          -  Diabetes secondary to a specific condition

          -  Recent internal malignancy (&lt;5 years)

          -  Recent major vascular event

          -  Drug or alcohol dependence

          -  Uncontrolled psychiatric disease

          -  Crippling cardiopulmonary disease

          -  Prohibitive anatomic features (extensive prior surgery, giant paraesophageal hernia)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason M Pfluke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wilford Hall Medical Center, United States Air Force</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wilford Hall Medical Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>O'Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, Strauss B, Marks S, Schachter L, Chapman L, Anderson M. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006 May 2;144(9):625-33.</citation>
    <PMID>16670131</PMID>
  </reference>
  <reference>
    <citation>Kakoulidis TP, Karringer A, Gloaguen T, Arvidsson D. Initial results with sleeve gastrectomy for patients with class I obesity (BMI 30-35 kg/m2). Surg Obes Relat Dis. 2009 Jul-Aug;5(4):425-8. doi: 10.1016/j.soard.2008.09.009. Epub 2008 Sep 26.</citation>
    <PMID>18996758</PMID>
  </reference>
  <reference>
    <citation>Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007 Oct;21(10):1810-6. Epub 2007 Mar 14.</citation>
    <PMID>17356932</PMID>
  </reference>
  <reference>
    <citation>Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008 Jan 23;299(3):316-23. doi: 10.1001/jama.299.3.316.</citation>
    <PMID>18212316</PMID>
  </reference>
  <reference>
    <citation>Cohen R, Pinheiro JS, Correa JL, Schiavon CA. Laparoscopic Roux-en-Y gastric bypass for BMI &lt; 35 kg/m(2): a tailored approach. Surg Obes Relat Dis. 2006 May-Jun;2(3):401-4, discussion 404.</citation>
    <PMID>16925363</PMID>
  </reference>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2009</study_first_submitted>
  <study_first_submitted_qc>August 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2009</study_first_posted>
  <last_update_submitted>January 12, 2015</last_update_submitted>
  <last_update_submitted_qc>January 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2015</last_update_posted>
  <responsible_party>
    <name_title>Jason M. Pfluke, MD MAJ USAF MC</name_title>
    <organization>Wilford Hall Medical Center, United States Air Force</organization>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Diabetes mellitus, Type 2</keyword>
  <keyword>Sleeve gastrectomy</keyword>
  <keyword>Metabolic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

